Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556655 · ClinicalTrials.gov registry record · NA

Brain Stimulation Effects on Cognitive Task Performance

A NA study of Cognitive Function, sponsored by Colorado State University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05556655: Recruiting NA study of Cognitive Function, sponsored by Colorado State University.

NCT05556655 is a NA study of Cognitive Function that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 100 participants, below the 493-participant average among 20 other Cognitive Function trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556655, a NA study of Cognitive Function, is actively recruiting participants, sponsored by Colorado State University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine optimal task design parameters for the measurement of transcranial magnetic stimulation (TMS) effects on cognition.

Primary Outcome

Mean item accuracy on a computerized Sternberg memory task.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

Colorado

  • Colorado State University Department of Psychology - Fort Collins

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-04-20
Est. Completion 2027-01-01
Phase NA
Colorado State University

94 total trials

What NCT05556655 shows while recruiting

NCT05556655 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 493-participant average among 20 other Cognitive Function trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Cognitive Function appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT05556655 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05556655 about?

NCT05556655 is a clinical study titled "Brain Stimulation Effects on Cognitive Task Performance". The purpose of this study is to determine optimal task design parameters for the measurement of transcranial magnetic stimulation (TMS) effects on cognition.

What is the current status of trial NCT05556655?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-20. Estimated completion is 2027-01-01.

What conditions does trial NCT05556655 study?

This clinical trial studies the following conditions: Cognitive Function.

What interventions are being tested in trial NCT05556655?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05556655?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05556655 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05556655's enrollment target sits among peer trials

100 8th of 20 higher than 13 of 20 other Cognitive Function trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05556655, the US trial registry maintained by the National Library of Medicine. NCT05556655 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.